Rockwell Medical(RMTI)
Focus: Rockwell Medical is a publicly traded specialty pharmaceutical company focused on dialysis products and nephrology therapeutics for patients with end-stage renal disease. The company generates ~$101M in annual revenue with a lean operational footprint.
Profile data last refreshed 11h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at Rockwell Medical?
AI assessmentBest suited for mission-driven professionals seeking niche nephrology expertise and willing to accept financial volatility and limited growth runway.
Why Work Here
- Focused portfolio in high-need nephrology space with Triferic as established commercial product generating $101M revenue (FY2025).
- Public company status with potential for meaningful equity upside as a niche player in dialysis treatment.
Data completeness
7/9 — Strong
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
3 in 5yr
TRIFERIC
Hiring
Stable
Revenue
$101M
Key Products
LOE Approaching2.7yr
Help build intelligence for Rockwell Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.